Live Breaking News & Updates on Resource Use Among Elderly

Eighteen total abstracts accepted for presentation and publication, including results from four clinical trials evaluating epcoritamab in multiple treatment settings and patient populationsOral presentations highlighting new findings from a clinical trial of epcoritamab in patients with relapsed/refractory (R/R) dif. ....

San Diego , United States , New Jersey , United Kingdom , Hematol Hemoter , David Freundel , Andrew Carlsen , Judith Klimovsky , Exchange Commission , Lymphoma Research Foundation , Company Announcement , Outcomes Research , National Comprehensive Cancer Network , Abbvie Biotechnology Ltd , American Society Of Hematology , Discovery Research , Exposition Of The American Society Hematology , Global Communications Corporate Affairs , Data From The Observational National Lymphocare Study , European Union , Genmab Us Inc , Annual Meeting , American Society , Executive Vice President , Chief Development Officer , Epcoritamab Plus Lenalidomide ,